Deutsche Bank
CTNM

Deutsche Bank’s Contineum Therapeutics CTNM Stock Holding History

Deutsche Bank’s Portfolio CTNM Stock Details CTNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$430K Buy
+26,216
New +$344K ﹤0.01% 2854
2025
Q2 		– Sell
-16,079
Closed -$112K – 3769
2025
Q1 		$112K Hold
16,079
– – ﹤0.01% 3157
2024
Q4 		$236K Buy
+16,079
New +$255K ﹤0.01% 3025

Other funds holding CTNM

SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Deutsche Bank's CTNM Position: Q2 2026 in Review

Deutsche Bank opened a new position in Contineum Therapeutics (CTNM) in Q2 2026: 26,216 shares worth $430K. The stake represents ﹤0.01% of the portfolio and ranks #2854 among its holdings. This is a return to the name: Deutsche Bank previously reported a position in CTNM as recently as Q1 2025.

Deutsche Bank first reported a position in CTNM in Q4 2024 and has held it in 3 quarters since. 102 funds tracked by Wall St. Rank hold CTNM as of Q2 2026.

  • Deutsche Bank held 26,216 shares of Contineum Therapeutics worth $430K as of Q2 2026.
  • Contineum Therapeutics was a new Deutsche Bank position in Q2 2026.
  • Contineum Therapeutics made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #2854 holding.
  • Deutsche Bank first reported a position in Contineum Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • 102 funds tracked by Wall St. Rank held Contineum Therapeutics as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.